newsfilter
← Latest News
FDA Approved Drugs·

Approval of Rasonque, Nda #220910 (Type 1 - New Molecular Entity)

Approval Date: 08/26/2026; Drug Name: Rasonque, Nda #220910; Active Ingredients: DARAXONRASIB; Company: Revolution Medicines Inc; Submission Status: Approval; Submission Classification: Type 1 - New Molecular Entity; Application Number: 220910

Company
REVOLUTION MEDICINES INC
Keywords
REVOLUTION MEDICINES INC